Universal Study Design for Instrument Changes in Pharmaceutical Release Analytics
ELECTROPHORESIS · 2025
DOI: 10.1002/elps.70004 ↗Kurz gefasst
Fachartikel in der Zeitschrift ELECTROPHORESIS, 2025. Verfasst von Anne B Ries und 8 weiteren Autor:innen. Beteiligte Einrichtung: Quality Control, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany. Hauptthemen laut MEDLINE: Electrophoresis, Capillary, Pharmaceutical Preparations. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In pharmaceutical quality control (QC), analytical methods need to maintain release analytics over decades. Over a product's lifecycle, vendors may update instrument hardware and/or software, or a switch between vendors may become necessary upon discontinuation of an instrument. Both situations pose a challenge to pharmaceutical QC.We designed an efficient instrument comparability study to gain a comprehensive understanding of potential performance differences between instruments and therefore rationalize the risk assessment and decision process for a path forward. The results may either point out whether a full or partial re‐validation is necessary or whether a science‐based update can be pursued based on the data generated in the study. The study design is universally applicable to a substantial range of release analytical methods. In a straightforward setup of two experiments with the new instrument, a statistically meaningful data set is generated for comparison with available historical or validation data of the original instrument. In a Good Manufacturing Practice (GMP) environment, we implemented the study design in a benchmark study comparing the ICE3 and Maurice C imaged capillary isoelectric focusing (icIEF) instruments. The core‐study confirmed equal or better performance of the Maurice C in all parameters and serves as a basis for seamless continuation of release icIEF measurements on Maurice C.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Quality Control, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
- CMC Statistics BioPharma, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
ORCID-Profile: Anne B Ries
Zitieren
APA
Ries, A. B., Merkel, M. N., Coßmann, K., Paul, M., Grunwald, R., Klemmer, D., Hübner, F., Eggensperger, S., & Weiß, F. T. (2025). Universal Study Design for Instrument Changes in Pharmaceutical Release Analytics. ELECTROPHORESIS. https://doi.org/10.1002/elps.70004
Vancouver
Ries AB, Merkel MN, Coßmann K, Paul M, Grunwald R, Klemmer D, et al. Universal Study Design for Instrument Changes in Pharmaceutical Release Analytics. ELECTROPHORESIS. 2025. doi:10.1002/elps.70004
BibTeX
@article{Ries2025,
author = {Ries, Anne B and Merkel, Maximilian N and Coßmann, Kristina and Paul, Marina and Grunwald, Robin and Klemmer, Daniel and Hübner, Franziska and Eggensperger, Sabine and Weiß, Frederik T},
title = {Universal Study Design for Instrument Changes in Pharmaceutical Release Analytics},
journal = {ELECTROPHORESIS},
year = {2025},
doi = {10.1002/elps.70004}
}
EUVIMED